Talking with your doctor

Similar documents
SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII)

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)

INDIVIOR RESPONDS TO COURT RULING IN ANDA LITIGATION AND ANNOUNCES INTENTION TO APPEAL

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)

MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII)

Share the important information in this Medication Guide with members of your household.

Orexo completes 1,080 patient REZOLV study and reports on improved treatment of opioid dependent patients

Indivior to Divest Interest in China

Patient Information Leaflet

Tuscarawas County Health Department. Vivitrol Treatment Consent

Medication Guide. Medication Guide. Lazanda (La-ZAN-da) CII. (fentanyl) nasal spray 100 mcg, 400 mcg

Learn how MORPHABOND ER can help manage your pain

6. Never give SUBSYS to anyone else, even if they have the same symptoms you have. It may harm them or even cause death.

MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP

SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets. Risk Evaluation and Mitigation Strategy (REMS) Program

MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution

MEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only

Medication Guide BELBUCATM (bel-bue-kuh) (buprenorphine) buccal film, CIII BELBUCA is:

Questions & Answers About Probuphine. Here are the answers to some questions you may have about the Probuphine implant:

Doctor Discussion Guide

MEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment

Now available. A maintenance dose of SUBOXONE mg once daily is clinically effective for most patients*1. Once-daily dosing in a single tablet

FOLLOW DIRECTIONS. How to Use Methadone Safely. U.S. Department of Health & Human Services

MEDICATION GUIDE CODEINE SULFATE (koh-deen) CII Oral Solution

attempts to commit suicide acting aggressive, being angry, or violent

MEDICATION ASSISTED TREATMENT

Brief History of Methadone Maintenance Treatment

Slow Release Opioids. Morphine (Zomorph/MST) Oxycodone (Longtec, Oxycontin) Tapentadol (Palexia) For the Treatment of Pain

What is the most important information I should know about Morphine Sulfate Oral Solution?

Less pain in my life helps me get back to living.

MEDICATION GUIDE. ACTIQ (AK-tik) CII (fentanyl citrate) oral transmucosal lozenge 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, 1600 mcg

TEMGESIC Injection Buprenorphine (as hydrochloride)

The safety concerns defined with the reference product apply to Buprenorphine-Naloxone 2/0.5 mg, 8/2 mg, sublingual tablets.

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Controlled Substance and Wellness Agreement

Medication Guide Fentanyl transdermal system, CII Rx Only Fentanyl transdermal system is: A strong prescription pain medicine that contains an opioid

Welcome to the Braeburn Access Program for PROBUPHINE (buprenorphine) implant for subdermal

SUBOXONE Sublingual Tablets Buprenorphine Hydrochloride + Naloxone Hydrochloride Consumer Medicine Information

the facts about BUPRENORPHINE for Treatment of Opioid Addiction

Prescription Opioids

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

MEDICATION GUIDE. What is the most important information I should know about oral transmucosal fentanyl citrate?

SUBLOCADE Expected to be Available to U.S. Patients in Q This announcement contains inside information.

CONSENT FOR TREATMENT WITH NALTREXONE

Indivior Provides Update on Key Business Drivers and Expectations. This announcement contains inside information.

Medication Guide. Page 1 of o pain after surgery o headache or migraine o dental pain

MIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam

Buprenorphine Patch (Transtec Patch)

Medication Guide Fentanyl Transdermal System, CII (fĕn tə-nĭl) Fentanyl transdermal system is:

PATIENT INFORMATION LEAFLET TEXAMER

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Medication Guide Clonazepam Tablets USP (kloe-na-za-pam)

Medication-Assisted Treatment (MAT) Overview

Titan Pharmaceuticals Reports Positive Initial Results Of Probuphine Relaunch

Medication Information for Parents and Teachers

Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet

IMPORTANT: PLEASE READ

Patient information sheet: BuTrans Patch This information should be read in conjunction with the Taking Opioids for pain information leaflet

How should I take NUCYNTA oral solution?

Pain CONCERN. Medicines for long-term pain. Opioids

Guide for Patients and Caregivers

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor

Buprenorphine & Controlled Substance Treatment Agreement

Package leaflet: Information for the patient. Selincro 18 mg film-coated tablets nalmefene

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

MEDICATION GUIDE ONFI (ON-fee) (clobazam) Tablets and Oral Suspension

Opioids for persistent pain: Information for patients. The British Pain Society's

What is the most important information I should know about midazolam?

MEDICATION GUIDE. BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

MEDICATION GUIDE. The risk of getting a serious skin rash is higher if you:

Treatment of drug dependence What you need to know

Could your uncontrollable movements be tardive dyskinesia (TD)?

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

SANDOMIGRAN. 0.5mg tablet Pizotifen malate

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Pregabalin. For the Treatment of Pain

MEDICATION GUIDE LAMOTRIGINE TABLETS

PATIENT INFORMATION LEAFLET TAPENCET ER 50 (TAPENTADOL EXTENDED RELEASE 50 MG, TABLETS)

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.

Have you already tried different drugs for your schizophrenia? Here s another option you and your doctor may want to consider.

Latest Press Release. How much for 30 mg adderall

Your B.E.D. Discussion Guide

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

Strengthening our global leadership in treatment of addiction. Jefferies Healthcare Conference New York June 7 th 2016

What is the most important information I should know about carbamazepine tablets or chewable tablets?

XYZAL 5 MG FILM-COATED TABLET

IMPORTANT: PLEASE READ

Buprenorphine pharmacology

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration

A GUIDE TO TALKING WITH YOUR DOCTOR ABOUT EPIDIOLEX

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINEPATIENT MEDICATION INFORMATION

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

Package leaflet: Information for the patient. Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate

MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets

Transcription:

SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may adjust your treatment plan accordingly. Speak frankly and honestly. What you tell your doctor is private and should not be shared without your permission. Add your own questions, and take this guide along on your doctor visit. Use it to help you bring up things you want to discuss. This list is not all inclusive. Your doctor may require additional information from you. What does my doctor need to know before I start treatment? Be specific. Tell your doctor: When you began misusing opioids, what you take, how much, and how often Whether you got prescriptions from several doctors If you crushed the pills to take them in another form, such as snorting or injecting If you ve tried to stop using opioids before and felt ill (you may have had withdrawal symptoms) If you used heroin or other illicit drugs Anything else that might help your doctor understand what you ve been experiencing Get all of your questions answered Create a list of questions to ask your doctor, and bring them along so you don t forget anything. You might be wondering: What are my treatment options? How can medication-assisted treatment with SUBOXONE Film help me? Do I really need treatment? What side effects have people had with SUBOXONE Film? How long does treatment typically last? Will I experience withdrawal? Why is it important to get my dosage right? Why do I need counseling? What factors could put my treatment at risk, and how do I minimize that risk? What s my role in treatment? Write in your own questions here: 1 2 3 4 5 Please see attached Important Safety Information SUBOXONE, SUBUTEX and Here to Help are registered trademarks of Indivior UK Limited. The Here to Help Program 866-973-HERE (866-973-4373) P1177150 81 2016 Indivior Inc. SBF-UM-P-1177-1508(1)

IMPORTANT SAFETY INFORMATION Indication SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) is a prescription medicine indicated for treatment of opioid dependence and should be used as part of a complete treatment plan to include counseling and psychosocial support. Treatment should be initiated under the direction of physicians qualified under the Drug Addiction Treatment Act. Important Safety Information Do not take SUBOXONE Film if you are allergic to buprenorphine or naloxone as serious negative effects, including anaphylactic shock, have been reported. SUBOXONE Film can be abused in a manner similar to other opioids, legal or illicit. SUBOXONE Film contains buprenorphine, an opioid that can cause physical dependence with chronic use. Physical dependence is not the same as addiction. Your doctor can tell you more about the difference between physical dependence and drug addiction. Do not stop taking SUBOXONE Film suddenly without talking to your doctor. You could become sick with uncomfortable withdrawal symptoms because your body has become used to this medicine. SUBOXONE Film can cause serious life-threatening breathing problems, overdose and death, particularly when taken by the intravenous (IV) route in combination with benzodiazepines or other medications that act on the nervous system (ie, sedatives, tranquilizers, or alcohol). It is extremely dangerous to take nonprescribed benzodiazepines or other medications that act on the nervous system while taking SUBOXONE Film. You should not drink alcohol while taking SUBOXONE Film, as this can lead to loss of consciousness or even death. Death has been reported in those who are not opioid dependent. Your doctor may monitor liver function before and during treatment. SUBOXONE Film is not recommended in patients with severe hepatic impairment and may not be appropriate for patients with moderate hepatic impairment. However, SUBOXONE Film may be used with caution for maintenance treatment in patients with moderate hepatic impairment who have initiated treatment on a buprenorphine product without naloxone. Keep SUBOXONE Film out of the sight and reach of children. Accidental or deliberate ingestion of SUBOXONE Film by a child can cause severe breathing problems and death. Do not take SUBOXONE Film before the effects of other opioids (eg, heroin, hydrocodone, methadone, morphine, oxycodone) have subsided as you may experience withdrawal symptoms. Injecting the SUBOXONE Film product may cause serious withdrawal symptoms such as pain, cramps, vomiting, diarrhea, anxiety, sleep problems, and cravings. Before taking SUBOXONE Film, tell your doctor if you are pregnant or plan to become pregnant. If you are pregnant or become pregnant while taking SUBOXONE Film, alert your doctor immediately and you should report it using the contact information provided below.* Neonatal opioid withdrawal syndrome (NOWS) is an expected and treatable outcome of prolonged use of opioids during pregnancy, whether that use is medically-authorized or illicit. Unlike opioid withdrawal syndrome in adults, NOWS may be life-threatening if not recognized and treated in the neonate. Healthcare professionals should observe newborns for signs of NOWS and manage accordingly. Before taking SUBOXONE Film, talk to your doctor if you are breastfeeding or plan to breastfeed your baby. The active ingredients of SUBOXONE Film can pass into your breast milk. You and your doctor should consider the development and health benefits of breastfeeding along with your clinical need for SUBOXONE Film and should also consider any potential adverse effects on the breastfed child from the drug or from the underlying maternal condition. Do not drive, operate heavy machinery, or perform any other dangerous activities until you know how SUBOXONE Film affects you. Buprenorphine in SUBOXONE Film can cause drowsiness and slow reaction times during doseadjustment periods. Common side effects of SUBOXONE Film include nausea, vomiting, drug withdrawal syndrome, headache, sweating, numb mouth, constipation, painful tongue, redness of the mouth, intoxication (feeling lightheaded or drunk), disturbance in attention, irregular heartbeat, decrease in sleep, blurred vision, back pain, fainting, dizziness, and sleepiness. This is not a complete list of potential adverse events associated with SUBOXONE Film. Please see full Prescribing Information for a complete list. * To report negative side effects associated with taking SUBOXONE Film, please call 1-877-782-6966. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. For more information about SUBOXONE Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablets (CIII), or SUBUTEX (buprenorphine) Sublingual Tablets (CIII), please see the respective full Prescribing Information and Medication Guide at www.suboxonerems.com. SBF-UM-P-1162-1409(2) P1162140 92

SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may adjust your treatment plan accordingly. Speak frankly and honestly. What you tell your doctor is private and should not be shared without your permission. Add your own questions, and take this guide along on your doctor visit. Use it to help you bring up things you want to discuss. This list is not all inclusive. Your doctor may require additional information from you. What does my doctor need to know before I start treatment? Be specific. Tell your doctor: What happened with your previous treatment, including What was working What you were dissatisfied with If this is your first time being treated with medication What you re looking for from your treatment your short- and long-term goals Anything else that might help your doctor understand your concerns Get all of your questions answered Create a list of questions to ask your doctor, and bring them along so you don t forget anything. You might be wondering: How do my previous treatment and SUBOXONE Film differ? What other treatment options are available? How can treatment with SUBOXONE Film help me? What side effects have people had with SUBOXONE Film? How long does treatment typically last? Will I experience withdrawal? Why is it important to get my dosage right? Do I need counseling? What factors could put my treatment at risk, and how do I minimize that risk? What s my role in treatment? Write in your own questions here: 1 2 3 4 5 Please see attached Important Safety Information SUBOXONE, SUBUTEX and Here to Help are registered trademarks of Indivior UK Limited. The Here to Help Program 866-973-HERE (866-973-4373) P1177150 81 2016 Indivior Inc. SBF-UM-P-1177-1508(1)

IMPORTANT SAFETY INFORMATION Indication SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) is a prescription medicine indicated for treatment of opioid dependence and should be used as part of a complete treatment plan to include counseling and psychosocial support. Treatment should be initiated under the direction of physicians qualified under the Drug Addiction Treatment Act. Important Safety Information Do not take SUBOXONE Film if you are allergic to buprenorphine or naloxone as serious negative effects, including anaphylactic shock, have been reported. SUBOXONE Film can be abused in a manner similar to other opioids, legal or illicit. SUBOXONE Film contains buprenorphine, an opioid that can cause physical dependence with chronic use. Physical dependence is not the same as addiction. Your doctor can tell you more about the difference between physical dependence and drug addiction. Do not stop taking SUBOXONE Film suddenly without talking to your doctor. You could become sick with uncomfortable withdrawal symptoms because your body has become used to this medicine. SUBOXONE Film can cause serious life-threatening breathing problems, overdose and death, particularly when taken by the intravenous (IV) route in combination with benzodiazepines or other medications that act on the nervous system (ie, sedatives, tranquilizers, or alcohol). It is extremely dangerous to take nonprescribed benzodiazepines or other medications that act on the nervous system while taking SUBOXONE Film. You should not drink alcohol while taking SUBOXONE Film, as this can lead to loss of consciousness or even death. Death has been reported in those who are not opioid dependent. Your doctor may monitor liver function before and during treatment. SUBOXONE Film is not recommended in patients with severe hepatic impairment and may not be appropriate for patients with moderate hepatic impairment. However, SUBOXONE Film may be used with caution for maintenance treatment in patients with moderate hepatic impairment who have initiated treatment on a buprenorphine product without naloxone. Keep SUBOXONE Film out of the sight and reach of children. Accidental or deliberate ingestion of SUBOXONE Film by a child can cause severe breathing problems and death. Do not take SUBOXONE Film before the effects of other opioids (eg, heroin, hydrocodone, methadone, morphine, oxycodone) have subsided as you may experience withdrawal symptoms. Injecting the SUBOXONE Film product may cause serious withdrawal symptoms such as pain, cramps, vomiting, diarrhea, anxiety, sleep problems, and cravings. Before taking SUBOXONE Film, tell your doctor if you are pregnant or plan to become pregnant. If you are pregnant or become pregnant while taking SUBOXONE Film, alert your doctor immediately and you should report it using the contact information provided below.* Neonatal opioid withdrawal syndrome (NOWS) is an expected and treatable outcome of prolonged use of opioids during pregnancy, whether that use is medically-authorized or illicit. Unlike opioid withdrawal syndrome in adults, NOWS may be life-threatening if not recognized and treated in the neonate. Healthcare professionals should observe newborns for signs of NOWS and manage accordingly. Before taking SUBOXONE Film, talk to your doctor if you are breastfeeding or plan to breastfeed your baby. The active ingredients of SUBOXONE Film can pass into your breast milk. You and your doctor should consider the development and health benefits of breastfeeding along with your clinical need for SUBOXONE Film and should also consider any potential adverse effects on the breastfed child from the drug or from the underlying maternal condition. Do not drive, operate heavy machinery, or perform any other dangerous activities until you know how SUBOXONE Film affects you. Buprenorphine in SUBOXONE Film can cause drowsiness and slow reaction times during doseadjustment periods. Common side effects of SUBOXONE Film include nausea, vomiting, drug withdrawal syndrome, headache, sweating, numb mouth, constipation, painful tongue, redness of the mouth, intoxication (feeling lightheaded or drunk), disturbance in attention, irregular heartbeat, decrease in sleep, blurred vision, back pain, fainting, dizziness, and sleepiness. This is not a complete list of potential adverse events associated with SUBOXONE Film. Please see full Prescribing Information for a complete list. * To report negative side effects associated with taking SUBOXONE Film, please call 1-877-782-6966. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. For more information about SUBOXONE Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablets (CIII), or SUBUTEX (buprenorphine) Sublingual Tablets (CIII), please see the respective full Prescribing Information and Medication Guide at www.suboxonerems.com. SBF-UM-P-1162-1409(2) P1162140 92

SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Medication, counseling, and behavioral therapy can be used together to treat opioid dependence. Talking with your healthcare team keeps them aware of your situation so they may adjust your treatment plan accordingly. Speak frankly and honestly. What you tell your doctor is private and should not be shared without your permission. Add your own questions, and take this guide along on your doctor visit. Use it to help you bring up things you want to discuss. This list is not all inclusive. Your doctor may require additional information from you. What does my doctor need to know before I start treatment? Be specific. Tell your doctor: How long you were in treatment Why and how you stopped treatment If you relapsed, how it happened and for how long What wasn t working for you the last time in treatment Whether you had breakthrough withdrawal symptoms or cravings Whether your dose might have been too low or too high What you expect to get out of treatment Anything else that might help your doctor understand what you ve been experiencing Get all of your questions answered Create a list of questions to ask your doctor, and bring them along so you don t forget anything. You might be wondering: What are my options for treatment? Will treatment with SUBOXONE Film work for me this time? What should I consider doing differently? What can you and my treatment team do differently? What side effects have people had with SUBOXONE Film? How long does treatment typically last? Why is it important to get my dosage right? Do I really need counseling? What factors could put my treatment at risk, and how do I minimize that risk? What s my role in treatment? Write in your own questions here: 1 2 3 4 5 Please see attached Important Safety Information SUBOXONE, SUBUTEX and Here to Help are registered trademarks of Indivior UK Limited. The Here to Help Program 866-973-HERE (866-973-4373) P1177150 81 2016 Indivior Inc. SBF-UM-P-1177-1508(1)

IMPORTANT SAFETY INFORMATION Indication SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) is a prescription medicine indicated for treatment of opioid dependence and should be used as part of a complete treatment plan to include counseling and psychosocial support. Treatment should be initiated under the direction of physicians qualified under the Drug Addiction Treatment Act. Important Safety Information Do not take SUBOXONE Film if you are allergic to buprenorphine or naloxone as serious negative effects, including anaphylactic shock, have been reported. SUBOXONE Film can be abused in a manner similar to other opioids, legal or illicit. SUBOXONE Film contains buprenorphine, an opioid that can cause physical dependence with chronic use. Physical dependence is not the same as addiction. Your doctor can tell you more about the difference between physical dependence and drug addiction. Do not stop taking SUBOXONE Film suddenly without talking to your doctor. You could become sick with uncomfortable withdrawal symptoms because your body has become used to this medicine. SUBOXONE Film can cause serious life-threatening breathing problems, overdose and death, particularly when taken by the intravenous (IV) route in combination with benzodiazepines or other medications that act on the nervous system (ie, sedatives, tranquilizers, or alcohol). It is extremely dangerous to take nonprescribed benzodiazepines or other medications that act on the nervous system while taking SUBOXONE Film. You should not drink alcohol while taking SUBOXONE Film, as this can lead to loss of consciousness or even death. Death has been reported in those who are not opioid dependent. Your doctor may monitor liver function before and during treatment. SUBOXONE Film is not recommended in patients with severe hepatic impairment and may not be appropriate for patients with moderate hepatic impairment. However, SUBOXONE Film may be used with caution for maintenance treatment in patients with moderate hepatic impairment who have initiated treatment on a buprenorphine product without naloxone. Keep SUBOXONE Film out of the sight and reach of children. Accidental or deliberate ingestion of SUBOXONE Film by a child can cause severe breathing problems and death. Do not take SUBOXONE Film before the effects of other opioids (eg, heroin, hydrocodone, methadone, morphine, oxycodone) have subsided as you may experience withdrawal symptoms. Injecting the SUBOXONE Film product may cause serious withdrawal symptoms such as pain, cramps, vomiting, diarrhea, anxiety, sleep problems, and cravings. Before taking SUBOXONE Film, tell your doctor if you are pregnant or plan to become pregnant. If you are pregnant or become pregnant while taking SUBOXONE Film, alert your doctor immediately and you should report it using the contact information provided below.* Neonatal opioid withdrawal syndrome (NOWS) is an expected and treatable outcome of prolonged use of opioids during pregnancy, whether that use is medically-authorized or illicit. Unlike opioid withdrawal syndrome in adults, NOWS may be life-threatening if not recognized and treated in the neonate. Healthcare professionals should observe newborns for signs of NOWS and manage accordingly. Before taking SUBOXONE Film, talk to your doctor if you are breastfeeding or plan to breastfeed your baby. The active ingredients of SUBOXONE Film can pass into your breast milk. You and your doctor should consider the development and health benefits of breastfeeding along with your clinical need for SUBOXONE Film and should also consider any potential adverse effects on the breastfed child from the drug or from the underlying maternal condition. Do not drive, operate heavy machinery, or perform any other dangerous activities until you know how SUBOXONE Film affects you. Buprenorphine in SUBOXONE Film can cause drowsiness and slow reaction times during doseadjustment periods. Common side effects of SUBOXONE Film include nausea, vomiting, drug withdrawal syndrome, headache, sweating, numb mouth, constipation, painful tongue, redness of the mouth, intoxication (feeling lightheaded or drunk), disturbance in attention, irregular heartbeat, decrease in sleep, blurred vision, back pain, fainting, dizziness, and sleepiness. This is not a complete list of potential adverse events associated with SUBOXONE Film. Please see full Prescribing Information for a complete list. * To report negative side effects associated with taking SUBOXONE Film, please call 1-877-782-6966. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. For more information about SUBOXONE Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablets (CIII), or SUBUTEX (buprenorphine) Sublingual Tablets (CIII), please see the respective full Prescribing Information and Medication Guide at www.suboxonerems.com. SBF-UM-P-1162-1409(2) P1162140 92